|
DMAA Drugs Made In America Acquisition Corp 2028614 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$1,726,897.00 |
| Balance Sheet |
|
Current Assets
|
$69,184.00 |
|
Assets
|
$146,903,435.00 |
|
Current Liabilities
|
$2,944,624.00 |
|
Liabilities
|
$9,136,624.00 |
|
Equity
|
$-7,406,216.00 |
|
Shares Out
|
10717143.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-335,857.00 |
|
Investing Cash Flow
|
$98,711,220.00 |
| Market Analysis |
Market Cap
|
$114,994,944.39 |
|
Price
|
$10.73 |
|
PB
|
2.46 |
|
EPS
|
-0.03 |
|
PE
|
47.95 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:36 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DMAA documents filed with the SEC.
DMAA Filings
Clear
